Description

Omnitrope (somatropin) is an injectable medication prescribed for the treatment of growth failure due to growth hormone deficiency (GHD), Prader-Willi syndrome, Small for Gestational Age, Turner syndrome, and Idiopathic Short Stature in children. It is also used to treat adults diagnosed with adult onset or childhood onset GHD.

Omnitrope is available in the following dosage forms and strengths:

• 5 mg/1.5 mL and 10 mg/1.5 mL prefilled sterile solution in a glass cartridge for use with the Omnitrope pen
• 5.8 mg vials

Directions

A healthcare provider will determine an appropriate Omnitrope dosage for you or your child. You should also receive training on the proper preparation, administration, and disposal of the medication.

Omnitrope may be injected in the thigh, buttocks, or abdomen. Tell your healthcare provider or pharmacist if you have any questions or concerns. Refer to the medication guide that comes with your prescription for detailed instructions for use.

Do not share needles, syringes, or pens with other people.

Storing Omnitrope:

Refrigerate Omnitrope between 2°C and 8°C (36°F to 46°F) in the original carton and out of light. It should not be frozen.

Ingredients

The active ingredient in Omnitrope is somatropin. Inactive ingredients may include benzyl alcohol, mannitol, poloxamer 188, dibasic sodium phosphate heptahydrate, monobasic sodium phosphate dihydrate, glycine, phenol, and water.

Contraindications

Patients with any of the following should not receive Omnitrope:

• Acute critical illness
• Prader-Willi Syndrome in children who are severely obese or have severe respiratory problems
• Active cancer
• Allergy to somatropin or to any of the other ingredients in Omnitrope
• Active proliferative or severe nonproliferative diabetic retinopathy
• Closed epiphyses in children

Cautions

• Before you or your child begins treatment with Omnitrope, talk to a healthcare provider about:
• All the prescription and over-the-counter medications you or your child takes
• You or your child’s allergies
• You or your child’s current health problems and past medical history
• Your pregnancy or breastfeeding status
• Omnitrope may be associated with the following:
• Acute critical illness
• Prader-Willi Syndrome in children: patients should be evaluated for upper airway obstruction and sleep apnea before they begin treatment with Omnitrope.
• Tumors. Patients should be evaluated for tumors that have progressed or keep coming back.
• Impaired glucose tolerance and diabetes: blood sugar levels should be checked periodically. Diabetic medications may require dose adjustments.
• Increased pressure around the brain that is usually reversible once Omnitrope is stopped or the dose is decreased.
• Serious allergic reactions
• Fluid retention, which may require a dose adjustment
• Decreased cortisol levels that may need an increased dose of glucocorticoid in those with hypoadrenalism
• Thyroid problems
• Slipped capital femoral epiphysis. Children should be evaluated if they start having a limp or pain in the hips and/or knees.
• Progression of scoliosis
• Pancreatitis

Side Effects

Injection site reactions, rashes, loss of fat tissue, and headaches are common Omnitrope side effects. However, other side effects may also occur. Immediately inform your healthcare provider of side effects that bother you or your child or won’t go away.

Searching for a competitive Omnitrope cost? You can buy Omnitrope injection here.

Reference:

Omnitrope. Princeton, NJ: Sandoz Inc.; 2019.

About Dr. Savannah Muncy (Page Author)

Dr. Muncy (PharmD) studied science and education as an undergraduate before attending the Appalachian College of Pharmacy where she completed her PharmD in three years. She is currently using her pharmacy and healthcare expertise to write medical content for clients all around the world. She is focused on delivering the most current, accurate, and engaging information to healthcare professionals and patients. Read More....

Product Code : 14439